These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10364671)

  • 1. Differential effect of advanced maternal age on prenatal diagnosis of trisomies 13, 18 and 21.
    Drugan A; Yaron Y; Zamir R; Ebrahim SA; Johnson MP; Evans MI
    Fetal Diagn Ther; 1999; 14(3):181-4. PubMed ID: 10364671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum alpha-fetoprotein and fetal autosomal trisomies.
    Doran TA; Cadesky K; Wong PY; Mastrogiacomo C; Capello T
    Am J Obstet Gynecol; 1986 Feb; 154(2):277-81. PubMed ID: 2418684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).
    Savva GM; Walker K; Morris JK
    Prenat Diagn; 2010 Jan; 30(1):57-64. PubMed ID: 19911411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need to reevaluate trisomy screening for advanced maternal age in prenatal diagnosis.
    Clark BA; Kennedy K; Olson S
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):812-6. PubMed ID: 8456886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand.
    Jaruthamsophon K; Sriplung H; Charalsawadi C; Limprasert P
    PLoS One; 2016; 11(11):e0165859. PubMed ID: 27812158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.
    Loane M; Morris JK; Addor MC; Arriola L; Budd J; Doray B; Garne E; Gatt M; Haeusler M; Khoshnood B; Klungsøyr Melve K; Latos-Bielenska A; McDonnell B; Mullaney C; O'Mahony M; Queisser-Wahrendorf A; Rankin J; Rissmann A; Rounding C; Salvador J; Tucker D; Wellesley D; Yevtushok L; Dolk H
    Eur J Hum Genet; 2013 Jan; 21(1):27-33. PubMed ID: 22713804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of chromosomal trisomies in the East of Ireland.
    McDonnell R; Monteith C; Kennelly M; Martin A; Betts D; Delany V; Lynch SA; Coulter-Smith S; Sheehan S; Mahony R
    J Public Health (Oxf); 2017 Dec; 39(4):e145-e151. PubMed ID: 27591300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maternal age on autosomal trisomies.
    Hassold T; Jacobs P; Kline J; Stein Z; Warburton D
    Ann Hum Genet; 1980 Jul; 44(1):29-36. PubMed ID: 7198887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13.
    Santorum M; Wright D; Syngelaki A; Karagioti N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):714-720. PubMed ID: 27549925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings.
    Carothers AD; Boyd E; Lowther G; Ellis PM; Couzin DA; Faed MJ; Robb A
    Genet Epidemiol; 1999; 16(2):179-90. PubMed ID: 10030400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies.
    Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):166-8. PubMed ID: 21570171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis in pregnancies at advanced maternal age (author's transl)].
    Wirtz A; Haas B; Krauss C; Stengel-Rutkowski S; Murken JD
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):422-30. PubMed ID: 149691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands.
    Bouman K; Bakker MK; Birnie E; Ter Beek L; Bilardo CM; van Langen IM; de Walle HE
    BMC Pregnancy Childbirth; 2017 Jan; 17(1):4. PubMed ID: 28056858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatally detectable markers for the diagnosis of autosomally trisomic fetuses in at-risk pregnancies.
    Salihu HM; Boos R; Schmidt W
    Am J Perinatol; 1997 May; 14(5):257-61. PubMed ID: 9259939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy recurrence: a reconsideration based on North American data.
    Warburton D; Dallaire L; Thangavelu M; Ross L; Levin B; Kline J
    Am J Hum Genet; 2004 Sep; 75(3):376-85. PubMed ID: 15248154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.